ChemicalBook > CAS DataBase List > NMS-P937 (NMS1286937)

NMS-P937 (NMS1286937)

Product Name
NMS-P937 (NMS1286937)
CAS No.
1034616-18-6
Chemical Name
NMS-P937 (NMS1286937)
Synonyms
PCM075;CS-1243;PCM 075;PCM-075;NMS-P937;NMS-1286937;NMS-1286937,NMS-P937;NMS-P937 (NMS1286937);Onvansertib (NMS-P937);Onvansertib(NMS-1286937
CBNumber
CB12715659
Molecular Formula
C24H27F3N8O3
Formula Weight
532.52
MOL File
1034616-18-6.mol
More
Less

NMS-P937 (NMS1286937) Property

Boiling point:
757.8±70.0 °C(Predicted)
Density 
1.57±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL in DMSO
form 
solid
pka
14.29±0.10(Predicted)
color 
Off-white to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
28762
Product name
NMS-1286937
Packaging
5mg
Price
$116
Updated
2024/03/01
Cayman Chemical
Product number
28762
Product name
NMS-1286937
Packaging
25mg
Price
$381
Updated
2024/03/01
Cayman Chemical
Product number
28762
Product name
NMS-1286937
Packaging
1mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
28762
Product name
NMS-1286937
Packaging
10mg
Price
$169
Updated
2024/03/01
TRC
Product number
N631750
Product name
NMS-P937
Packaging
1mg
Price
$125
Updated
2021/12/16
More
Less

NMS-P937 (NMS1286937) Chemical Properties,Usage,Production

Uses

NMS-P937 is a quinazoline derivative that is a potent and selective Polo-like kinase 1 inhibitor. Antitumor, anti-cancer.

Biological Activity

nms-1286937 (nms-p937) is a potent and selective inhibitor of polo-like kinase 1 (plk1) with ic50 value of 2 nm [1].plk1 is a serine/threonine protein kinase and plays an important role in the cell cycle control machinery. plk1 is involved in mitotic entry, bipolar mitotic spindle formation, centrosome duplication, transition from metaphase to anaphase, maintenance of genomic stability and cytokinesis [1].nms-1286937 is an orally bioavailable plk1 inhibitor. in cell lines established from solid tumors, leukemias and lymphomas, nms-p937 inhibited tumor cell proliferation. in a2780 cells, nms-p937 caused a g2-m cell-cycle block. in the mitotic phase, nms-p937 induced apoptotic death with misaligned chromosomes and an aberrant number of spindles poles [2]. in human osteosarcoma (os) cell lines, nms-p937 inhibited migration and clonogenic ability of cell lines. in abcb1-overexpressing, doxorubicin (dx)-resistant cell lines, combination of nms-p937 and dx reverted dx-resistance by inhibiting abcb1 transport activity [3].in harlan nu/nu mice, nms-p937 exhibited a good pharmacokinetic profile with low clearance, high auc and cmax, and acceptable oral bioavailability. in mice xenografted with human hct116 colon adenocarcinoma cells, nms-p937 (45 mg/kg) inhibited tumor growth by 83% and reduced body weight by 16% [1].

References

[1]. beria i, bossi rt, brasca mg, et al. nms-p937, a 4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline derivative as potent and selective polo-like kinase 1 inhibitor. bioorg med chem lett, 2011, 21(10): 2969-2974.
[2]. valsasina b, beria i, alli c, et al. nms-p937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies. mol cancer ther, 2012, 11(4): 1006-1016.
[3]. sero v, tavanti e, vella s, et al. targeting polo-like kinase 1 by nms-p937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance. invest new drugs, 2014, 32(6): 1167-1180.

NMS-P937 (NMS1286937) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

NMS-P937 (NMS1286937) Suppliers

Wuhan Co TC SR Technology Co., Ltd.
Tel
13487090306
Email
48011371@qq.com
Country
China
ProdList
164
Advantage
58
Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.
Tel
13771642864
Fax
1078336263
Email
snhuyu_2008@126.com
Country
China
ProdList
1112
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9458
Advantage
58
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Wuhan Kaymke Chemical Co., Ltd.,
Tel
027-027-87342388 18086026008
Fax
027-87342388
Email
sales@kaymke.com
Country
China
ProdList
3865
Advantage
55
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai YuanQi Biotechnology Co., Ltd.
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Country
China
ProdList
1250
Advantage
50
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4566
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9248
Advantage
55

1034616-18-6, NMS-P937 (NMS1286937)Related Search:


  • NMS-1286937
  • 4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
  • NMS-P937 (NMS1286937)
  • NMS-P937
  • NMS-1286937,NMS-P937
  • 1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide
  • CS-1243
  • 1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-
  • NMS-P937 (NMS1286937) USP/EP/BP
  • Onvansertib(NMS-1286937
  • 1-(2-Hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
  • Onvansertib (NMS-P937)
  • PCM 075
  • PCM075
  • PCM-075
  • 1034616-18-6
  • C24H27F3N8O3
  • Inhibitors